Evidence map›Paper›PMID 33467522›Full record

ReviewMolecules (Basel, Switzerland)2021

A Global Review on Short Peptides: Frontiers and Perspectives.

Vasso Apostolopoulos, Joanna Bojarska, Tsun-Thai Chai, Sherif Elnagdy, Krzysztof Kaczmarek, John Matsoukas, Roger New, Keykavous Parang, Octavio Paredes Lopez, Hamideh Parhiz and 15 more

Open access · goldAbstract readReview
In one paragraph

Review in Molecules (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 174 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
174citing papers in PubMed, 3 pooled it
22.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

174 citing papers in PubMed, 3 syntheses or guidelines pooled it, 378 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Novel Peptide-Triazole Conjugates: Strategic Synthesis, Antimicrobial Properties, and Molecular Docking Study.Journal of peptide science : an official publication of the European Peptide Society · 2026
    Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Ancient Latin-American food crops: An overview of their nutraceutical and antiobesity peptides.Food science and technology international = Ciencia y tecnologia de los alimentos internacional · 2026
    Review
  16. Article
  17. Article
  18. Review
  19. Review
  20. Review

114 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors at 16 institutions in 13 countries.

Vasso ApostolopoulosInstitute for Health and Sport, Victoria University, Melbourne, VIC 3030, Australia.ORCID 0000-0001-6788-2771
Joanna BojarskaInstitute of General and Ecological Chemistry, Faculty of Chemistry, Lodz University of Technology, Żeromskiego 116, 90-924 Lodz, Poland.ORCID 0000-0001-9190-6913
Tsun-Thai ChaiDepartment of Chemical Science, Faculty of Science, Universiti Tunku Abdul Rahman, Kampar 31900, Malaysia.ORCID 0000-0003-3716-1599
Sherif ElnagdyBotany and Microbiology Department, Faculty of Science, Cairo University, Gamaa St., Giza 12613, Egypt.ORCID 0000-0003-1331-8977
Krzysztof KaczmarekInstitute of Organic Chemistry, Faculty of Chemistry, Lodz University of Technology, Żeromskiego 116, 90-924 Lodz, Poland.ORCID 0000-0001-8806-7792
John MatsoukasInstitute for Health and Sport, Victoria University, Melbourne, VIC 3030, Australia.
Roger NewVaxcine (UK) Ltd., c/o London Bioscience Innovation Centre, London NW1 0NH, UK.
Keykavous ParangCenter for Targeted Drug Delivery, Department of Biomedical and Pharmaceutical Sciences, Chapman University School of Pharmacy, Harry and Diane Rinker Health Science Campus, Irvine, CA 92618, USA.ORCID 0000-0001-8600-0893
Octavio Paredes LopezCentro de Investigación y de Estudios Avanzados del IPN, Departamento de Biotecnología y Bioquímica, Irapuato 36824, Guanajuato, Mexico.ORCID 0000-0003-1583-7631
Hamideh ParhizInfectious Disease Division, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104-6073, USA.
Conrad O PereraSchool of Chemical Sciences, The University of Auckland, Private Bag 92019, Auckland 1142, New Zealand.
Monica PickholzDepartamento de Física, Facultad de Ciencias Exactas y Naturales, Universidad de Buenos Aires, Buenos Aires 1428, Argentina.
Milan RemkoRemedika, Luzna 9, 85104 Bratislava, Slovakia.
Michele SavianoInstitute of Crystallography (CNR), Via Amendola 122/o, 70126 Bari, Italy.
Mariusz SkwarczynskiSchool of Chemistry & Molecular Biosciences, The University of Queensland, St Lucia, QLD 4072, Australia.
Yefeng TangKey Laboratory of Bioorganic Phosphorus Chemistry & Chemical Biology (MOE), School of Pharma Ceutical Sciences, Tsinghua University, Beijing 100084, China.
Wojciech M WolfInstitute of General and Ecological Chemistry, Faculty of Chemistry, Lodz University of Technology, Żeromskiego 116, 90-924 Lodz, Poland.
Taku YoshiyaPeptide Institute, Inc., Osaka 567-0085, Japan.ORCID 0000-0002-7276-5614
Janusz ZabrockiInstitute of Organic Chemistry, Faculty of Chemistry, Lodz University of Technology, Żeromskiego 116, 90-924 Lodz, Poland.
Piotr ZielenkiewiczInstitute of Biochemistry and Biophysics, Polish Academy of Sciences, Pawinskiego 5a, 02-106 Warsaw, Poland.ORCID 0000-0001-8151-6874
Maha AlKhazindarBotany and Microbiology Department, Faculty of Science, Cairo University, Gamaa St., Giza 12613, Egypt.ORCID 0000-0002-3244-9377
Vanessa BarrigaInstitute for Health and Sport, Victoria University, Melbourne, VIC 3030, Australia.
Konstantinos KelaidonisNewDrug, Patras Science Park, 26500 Patras, Greece.
Elham Mousavinezhad SarasiaFaculty of Science & Technology, Middlesex University, The Burroughs, London NW4 4BT, UK.
Istvan TothSchool of Chemistry & Molecular Biosciences, The University of Queensland, St Lucia, QLD 4072, Australia.
Lodz University of Technology · PLCairo University · EGMiddlesex University · GBThe University of Queensland · AUVictoria University · AUInstitute of Biochemistry and Biophysics, Polish Academy of Sciences · PLInstitute of Crystallography · ITInstituto Politécnico Nacional · MXPeptide Institute (Japan) · JPTarget (United States) · USTsinghua University · CNUniversidad de Buenos Aires · ARUniversiti Tunku Abdul Rahman · MYUniversity of Auckland · NZUniversity of Calgary · CAUniversity of Pennsylvania · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Peptides are fragments of proteins that carry out biological functions. They act as signaling entities via all domains of life and interfere with protein-protein interactions, which are indispensable in bio-processes. Short peptides include fundamental molecular information for a prelude to the symphony of life. They have aroused considerable interest due to their unique features and great promise in innovative bio-therapies. This work focusing on the current state-of-the-art short peptide-based therapeutical developments is the first global review written by researchers from all continents, as a celebration of 100 years of peptide therapeutics since the commencement of insulin therapy in the 1920s. Peptide "drugs" initially played only the role of hormone analogs to balance disorders. Nowadays, they achieve numerous biomedical tasks, can cross membranes, or reach intracellular targets. The role of peptides in bio-processes can hardly be mimicked by other chemical substances. The article is divided into independent sections, which are related to either the progress in short peptide-based theranostics or the problems posing challenge to bio-medicine. In particular, the SWOT analysis of short peptides, their relevance in therapies of diverse diseases, improvements in (bio)synthesis platforms, advanced nano-supramolecular technologies, aptamers, altered peptide ligands and in silico methodologies to overcome peptide limitations, modern smart bio-functional materials, vaccines, and drug/gene-targeted delivery systems are discussed.

Indexed as

Amino AcidsAnti-Infective AgentsAntiviral AgentsComputer SimulationCosmeceuticalsCOVID-19 Drug TreatmentDietary SupplementsGene Transfer TechniquesHumansLactoferrinLipid BilayersNanostructuresPeptidesStem CellsVaccines, SubunitAmino AcidsAnti-Infective AgentsAntiviral AgentsCosmeceuticalsLactoferrinLipid BilayersPeptidesVaccines, Subunitaltered peptide ligandsant/super/agonistsaptamersbilayer interactionscancercell-penetrating peptidesconstrained amino acids and peptide (bio)mimeticscosmeceuticalsdiketopiperazinedrug design and drug/gene deliverySARS-COV-2short peptidessynthesisvaccines

Identifiers

PMID33467522
PMCPMC7830668
OpenAlexW3120960768

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.